Leave a Reply

Next Post

Minnesota doctor engaged in FDA-approved Hydroxychloroquine trials lacks volunteers

A Minnesota doctor is calling on healthcare workers and people who have tested positive for COVID-19 and are showing early symptoms of infection to participate in two of the first trials of the malaria drug Hydroxychloroquine to treat coronavirus patients. Dr. David Boulware, an infectious disease specialist from the University […]

You May Like